Skip to main content

The indicators of glucose variability

The Original Article was published on 09 April 2021

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Liu X, Dong H, Chu H. Baseline HbA1c in acute kidney injury after cardiac surgery. J Anesth. https://doi.org/10.1007/s00540-021-02928-6.

  2. 2.

    Lee S, Nam S, Bae J, Cho YJ, Jeon Y, Nam K. Intraoperative hyperglycemia in patients with an elevated preoperative C-reactive protein level may increase the risk of acute kidney injury after cardiac surgery. J Anesth. 2021;35:10–9.

    Article  Google Scholar 

  3. 3.

    Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38:838–42.

    CAS  Article  Google Scholar 

  4. 4.

    Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105:244–52.

    CAS  Article  Google Scholar 

  5. 5.

    Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C, ANZICS CORE Management Committee. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care. 2009;13:R91.

    Article  Google Scholar 

  6. 6.

    Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008–13.

    CAS  Article  Google Scholar 

  7. 7.

    Frontoni S, Di Bartolo P, Avogaro A, Bosi E, Paolisso G, Ceriello A. Glucose variability: an emerging target for the treatment of diabetes mellitus. Diabetes Res Clin Pract. 2013;102:86–95.

    CAS  Article  Google Scholar 

  8. 8.

    Nam K, Jeon Y, Kim WH, Jung DE, Kwon SM, Kang P, Cho YJ, Kim TK. Intraoperative glucose variability, but not average glucose concentration, may be a risk factor for acute kidney injury after cardiac surgery: a retrospective study. Can J Anaesth. 2019;66:921–33.

    Article  Google Scholar 

  9. 9.

    Skrha J, Soupal J, Skrha J Jr, Prazny M. Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord. 2016;17:103–10.

    CAS  Article  Google Scholar 

  10. 10.

    Gorst C, Kwok CS, Aslam S, Buchan I, Kontopantelis E, Myint PK, Heatlie G, Loke Y, Rutter MK, Mamas MA. Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care. 2015;38:2354–69.

    CAS  Article  Google Scholar 

  11. 11.

    Rodbard D. Glucose variability: a review of clinical applications and research developments. Diabetes Technol Ther. 2018;20:S25–215.

    Article  Google Scholar 

  12. 12.

    Cavalot F. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes. Diabetes Obes Metab. 2013;15(Suppl 2):3–8.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Karam Nam.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nam, K., Lee, S. The indicators of glucose variability. J Anesth 35, 600–601 (2021). https://doi.org/10.1007/s00540-021-02945-5

Download citation

Keywords

  • Glucose variability
  • Glycemic variability